Citations

Showing 10 of 108094 citations.

Clinical Outcomes and Severity of Acute Respiratory Distress Syndrome in 1154 COVID-19 Patients: An Experience Multicenter Retrospective Cohort Study
Mutair, Abbas Al , Alhumaid, Saad , Layqah, Laila , Shamou, Jinan , Ahmed, Gasmelseed Y. , Chagla, Hiba Hameed , Alsalman, Khulud, Alnasser, Fadhah Mohammed, Alhuqbani, Waad N., Alghadeer, Mohammed , Mohaini, Mohammad Al , Almahmoud, Sana , Al‐Tawfiq, Jaffar A. , Muhammad, Javed , Al‐Jamea, Lamiaa H. , Woodman, Alexander, Alsaleh, Ahmed, Alsedrah, Abdulaziz M., Alharbi, Hanan Fahad , Saha, Chandni, Rabaan, Ali A. , Alhumaid, Saad , Rabaan, Ali A , Koritala, Thoyaja , Alghadeer, Mohammed

Mayo Clinic

COVID | August 1, 2022 | Volume: 2 | Issue: 8 | Pages: 1102-1115

10.3390/covid2080081 Get It

Background: Acute Respiratory Distress Syndrome (ARDS) is caused by non-cardiogenic pulmonary edema and occurs in critically ill patients. It is one of the fatal complications observed among severe COVID-19 cases managed in intensive care units (ICU). Supportive lung-protective ventilation and prone positioning remain the mainstay interventions. Purpose: We describe the severity of ARDS, clinical outcomes, and management of ICU patients with laboratory-confirmed COVID-19 infection in multiple Saudi hospitals. Methods: A multicenter retrospective cohort study was conducted of critically ill patients who were admitted to the ICU with COVID-19 and developed ARDS. Results: During our study, 1154 patients experienced ARDS: 591 (51.2%) with severe, 415 (36.0%) with moderate, and 148 (12.8%) with mild ARDS. The mean sequential organ failure assessment (SOFA) score was significantly higher in severe ARDS with COVID-19 (6 ± 5, p = 0.006). Kaplan–Meier survival analysis showed COVID-19 patients with mild ARDS had a significantly higher survival rate compared to COVID-19 patients who experienced severe ARDS (p = 0.023). Conclusion: ARDS is a challenging condition complicating COVID-19 infection. It carries significant morbidity and results in elevated mortality. ARDS requires protective mechanical ventilation and other critical care supportive measures. The severity of ARDS is associated significantly with the rate of death among the patients.
Patients surviving COVID-19 had increased risk for incident diabetes vs. persons without COVID-19
Montori, Víctor M.

Mayo Clinic

Annals of Internal Medicine | August 1, 2022 | Volume: 175 | Issue: 8 | Pages: JC93

10.7326/j22-0052 | PMID 35914265 Get It

A New Measure of Posterior Morphology in Sagittal Craniosynostosis: The Occipital Bullet Index
Bins, Griffin P. , Cull, Deborah , Layton, Ryan G. , Kogan, Samuel, Zhou, Larry, David, Lisa R. , Dunson, Blake T. , Runyan, Christopher Michael

Mayo Clinic

No container title available | August 1, 2022 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.21203/rs.3.rs-1832781/v1 Get It

Abstract Background: Sagittal craniosynostosis (SC) is associated with scaphocephaly, an elongated narrow head shape. Assessment of regional severity in the scaphocephalic head is limited by the use of serial CT imaging or complex computer programing. Three-dimensional measurements of cranial surface morphology provide a radiation-free alternative for assessing cranial shape. This study describes the creation of an Occipital Bulleting Index (OBI), a novel tool using surface morphology to assess the regional severity in patients with SC. Methods: Surface imaging from CT scans or 3D photographs of 360 individuals with sagittal craniosynostosis and 221 normocephalic individuals were compared to identify differences in morphology. Cartesian grids were created on each individual’s surface mesh using equidistant axial and sagittal planes. Area under the curve (AUC) analyses were performed to identify trends in regional morphology and create measures capturing population differences.Results: The largest differences were located in the medial regions posteriorly. Using these population trends, a measure was created maximizing AUC. The Occipital Bullet index has an AUC of 0.72 with a sensitivity of 74% and a specificity of 61%. When the Frontal Bossing Index is applied in tandem, the two have a sensitivity of 94.7% and a specificity of 93.1%. Correlation between the two scores in individuals with SC was found to be negligible with an intraclass correlation coefficient of 0.018. Severity was found to be independent of age under 24 months, sex, and imaging modality.Conclusions: This index creates a tool for differentiating control head shapes from those with sagittal craniosynostosis, and has the potential to allow for objective evaluation of the regional severity, outcomes of different surgical techniques, and tracking shape changes in individuals over time, without the need for radiation.
Promoting Chronic Obstructive Pulmonary Disease Wellness through Remote Monitoring and Health Coaching: A Clinical Trial
Benzo, Roberto, Hoult, Johanna, McEvoy, Charlene , Clark, Matthew M. , Benzo, M.V. , Johnson, Margaret M. , Novotny, Paul J. , Johnson, Margaret , Novotny, Paul

Mayo Clinic

Annals of the American Thoracic Society | August 1, 2022 | Volume: 19 | Issue: 11 | Pages: 1808-1817

10.1513/annalsats.202203-214oc | PMID 35914215 Get It

Abstract Rationale Quality of life (QoL) matters the most to patients with chronic obstructive pulmonary disease (COPD) and is associated with healthcare usage and survival. Pulmonary rehabilitation is the most effective intervention in improving QoL but has low uptake and adherence. Home-based programs are a proposed solution. However, there is a knowledge gap on effective and sustainable home-based programs impacting QoL in patients with COPD. Objectives To determine whether remote patient monitoring with health coaching improves the physical and emotional disease-specific QoL measured by the Chronic Respiratory Questionnaire (CRQ). Methods This multicenter clinical trial enrolled 375 adult patients with COPD, randomized to a 12-week remote patient monitoring with health coaching (n = 188) or wait-list usual care (n = 187). Primary outcomes include physical and emotional QoL measured by the CRQ summary scores. Prespecified secondary outcomes included the CRQ domains: dyspnea, CRQ-fatigue, CRQ-emotions, CRQ-mastery, daily physical activity, self-management abilities, symptoms of depression/anxiety, emergency room/hospital admissions, and sleep. Results Participant age: 69 ± 9 years; 59% women; forced expiratory volume in 1 second percent predicted: 45 ± 19. At 12 weeks, there was a significant and clinically meaningful difference between the intervention versus the control group in the physical and emotional CRQ summary scores: change difference (95% confidence interval): 0.54 points (0.36–0.73), P < 0.001; 0.51 (0.39–0.69), P < 0.001, respectively. In addition, all CRQ domains, self-management, daily physical activity, sleep, and depression scores improved (P < 0.01). CRQ changes were maintained at 24 weeks. Conclusions Remote monitoring with health coaching promotes COPD wellness and behavior change, given its effect on all aspects of QoL, self-management, daily physical activity, sleep, and depression scores. It represents an effective option for home-based rehabilitation. Clinical trial registered with clinicaltrials.gov (NCT 03480386).
Relationships among Clinical Factors and Patient‐reported Outcome Measures in Adults with Convergence Insufficiency
Lorenzana, Ingryd J., Leske, David A. , Dean, Trevano W., Jenewein, Erin C. , Dagi, Linda R. , Beal, Casey J. , Retnasothie, Dashaini V., Esposito, Christina , Erzurum, S. Ayse , Aldrich, Amy E., Crouch, Eric R. , Li, Zhuokai , Kraker, Raymond T. , Holmes, Jonathan M. , Group, The Pediatric Eye Disease Investigator, Larson, Scott A. , Miller, Aaron M. , Hatt, Sarah R. , Pang, Yi , Cotter, Susan A. , Group, The Pediatric Eye Disease Investigator, Holmes, Jonathan M.

Mayo Clinic

Optometry and Vision Science | August 1, 2022 | Volume: 99 | Issue: 9 | Pages: 692-701

10.1097/opx.0000000000001929 | PMID 35914096 Get It

SIGNIFICANCE When exploring relationships among clinical measures and patient‐reported outcome measures in adults with convergence insufficiency, worse symptoms (Convergence Insufficiency Symptom Survey [CISS] score) seemed to be correlated with worse reading function domain score (Adult Strabismus‐20 quality‐of‐life questionnaire). After treatment, improved symptoms were associated with improved reading function quality of life. PURPOSE This study aimed to explore relationships between clinical measures and patient‐reported outcome measures in adults undergoing treatment for symptomatic convergence insufficiency. METHODS In a prospective multicenter observational study, we evaluated adults with symptomatic convergence insufficiency (i.e., clinical measures of near exodeviation, receded near point of convergence, reduced near positive fusional vergence; CISS score ≥21). Fifty‐seven participants treated with vision therapy/exercises (n = 35) or base‐in prism (n = 22) were analyzed. Spearman correlation coefficients ( R ) were used to assess associations among the three clinical measures and patient‐reported outcome measures (CISS, Diplopia Questionnaire, four Adult Strabismus‐20 quality‐of‐life domains) before treatment (baseline) and after 10 weeks and 1 year. Associations were interpreted to be present when the lower limit of the 95% confidence interval (CI) was moderate to strong ( R ≥ 0.4). RESULTS Among multiple exploratory analyses, the only moderate to strong baseline correlation was between worse CISS and worse Adult Strabismus‐20 reading function scores ( R = 0.62; 95% CI, 0.43 to 0.76). Regarding change in measures with treatment, the only moderate to strong correlations were between improved CISS and improved Adult Strabismus‐20 reading function scores for prism at 10 weeks ( R = 0.78; 95% CI, 0.52 to 0.91) and 1 year ( R = 0.85; 95% CI, 0.65 to 0.94) and for vision therapy/exercises at 1 year ( R = 0.78; 95% CI, 0.57 to 0.89). CONCLUSIONS In exploratory analyses, we found positive correlations between CISS symptom scores and reading function quality‐of‐life scores. The absence of correlations between symptoms and individual clinical measures is consistent with clinical experience that, in convergence insufficiency, symptoms and clinical findings can be discordant.
Surveillance Imaging vs Symptomatic Recurrence Detection and Survival in Stage II-III Breast Cancer (AFT-01)
Schumacher, Jessica R. , Neuman, Heather B. , Yu, Menggang , Vanness, David J. , Si, Yajuan , Burnside, Elizabeth S. , Ruddy, Kathryn J. , Schrag, Deborah , Edge, Stephen B. , Zhang, Ying , Jacobs, Elizabeth A. , Havlena, Jeffrey , Francescatti, Amanda B. , Winchester, David P., McKellar, Daniel P., Spears, Patricia A. , Kozower, Benjamin D. , Chang, George J. , Greenberg, Caprice C. , Group, for the Alliance ACS-CRP CCDR Breast Cancer Surveillance Working, Green, Bettye, Perlmutter, Jane , Berger, Elizabeth R. , Punglia, Rinaa S. , Chen, Ronald, Brys, Nicole, Schrag, Deborah , Burnside, Elizabeth S , Yu, Menggang , Partridge, Ann H. , Group, for the Alliance ACS-CRP CCDR Breast Cancer Surveillance Working, Ballman, Karla V. , Gavin, Patrick G. , Chen, Ronald C. , Adesoye, Taiwo

Mayo Clinic

JNCI: Journal of the National Cancer Institute | August 1, 2022 | Volume: 114 | Issue: 10 | Pages: 1371-1379

10.1093/jnci/djac131 | PMID 35913454 Get It

Abstract Background Guidelines for follow-up after locoregional breast cancer treatment recommend imaging for distant metastases only in the presence of patient signs and/or symptoms. However, guidelines have not been updated to reflect advances in imaging, systemic therapy, or the understanding of biological subtype. We assessed the association between mode of distant recurrence detection and survival. Methods In this observational study, a stage-stratified random sample of women with stage II-III breast cancer in 2006-2007 and followed through 2016 was selected, including up to 10 women from each of 1217 Commission on Cancer facilities (n = 10 076). The explanatory variable was mode of recurrence detection (asymptomatic imaging vs signs and/or symptoms). The outcome was time from initial cancer diagnosis to death. Registrars abstracted scan type, intent (cancer-related vs not, asymptomatic surveillance vs not), and recurrence. Data were merged with each patient’s National Cancer Database record. Results Surveillance imaging detected 23.3% (284 of 1220) of distant recurrences (76.7%, 936 of 1220 by signs and/or symptoms). Based on propensity-weighted multivariable Cox proportional hazards models, patients with asymptomatic imaging compared with sign and/or symptom detected recurrences had a lower risk of death if estrogen receptor (ER) and progesterone receptor (PR) negative, HER2 negative (triple negative; hazard ratio [HR] = 0.73, 95% confidence interval [CI] = 0.54 to 0.99), or HER2 positive (HR = 0.51, 95% CI = 0.33 to 0.80). No association was observed for ER- or PR-positive, HER2-negative (HR = 1.14, 95% CI = 0.91 to 1.44) cancers. Conclusions Recurrence detection by asymptomatic imaging compared with signs and/or symptoms was associated with lower risk of death for triple-negative and HER2-positive, but not ER- or PR-positive, HER2-negative cancers. A randomized trial is warranted to evaluate imaging surveillance for metastases results in these subgroups.
Pain, Opioid Analgesics, and Cognition: A Conceptual Framework in Older Adults
Warner, Nafisseh S. , Verdoorn, Brandon P. , Hooten, W. Michael , Warner, David O. , Hooten, W Michael , Warner, David O , Warner, Nafisseh , Mielke, Michelle M. , Knopman, David S. , Habermann, Elizabeth B.

Mayo Clinic

Pain Medicine | August 1, 2022 | Volume: 24 | Issue: 2 | Pages: 171-181

10.1093/pm/pnac113 | PMID 35913452 Get It

AbstractChronic pain is highly prevalent in older adults and is associated with poor functional outcomes. Furthermore, opioid analgesics are commonly utilized for the treatment of pain in older adults despite well-described adverse effects. Importantly, both chronic pain and opioid analgesics have been linked with impairments in cognitive function, though data are limited. In this manuscript we summarize the evidence and critical knowledge gaps regarding the relationships between pain, opioid analgesics, and cognition in older adults. Furthermore, we provide a conceptual framework to guide future research in the development, implementation, and evaluation of strategies to optimize analgesic outcomes in older adults while minimizing deleterious effects on cognition.
Color Vision Deficiency Survey in Anatomic Pathology
Flotte, Thomas J. , Cornell, Lynn D. , Cornell, Lynn , Flotte, Thomas James

Mayo Clinic

American Journal of Clinical Pathology | August 1, 2022 | Volume: 158 | Issue: 4 | Pages: 516-520

10.1093/ajcp/aqac081 | PMID 35913114 Get It

Abstract Objectives To learn what color vision–deficient pathologists and cytotechnologists consider their most significant problems and advantages as well as any accommodations. Methods An anonymous online survey developed for practicing pathologists and cytotechnologists regarding their experiences with stains was sent to the members of 4 national societies. Results We received 377 responses. Twenty-three people, all men, identified themselves as color vision deficient, with 22 reporting red-green color vision deficiency and 1 reporting uncertain type. Eight pathologists and cytotechnologists indicated that they thought that their color vision deficiency conferred advantages to them, including a greater appreciation of morphology, with less confusion resulting from variations in stain quality or intensity. Nineteen pathologists and cytotechnologists thought that their color vision deficiency conferred disadvantages; the most common disadvantages stated were the identification of eosinophils and acid-fast bacilli. Other difficulties included interpretation of RBCs and nucleoli and sometimes Alcian blue, Brown and Brenn, Congo red, crystal violet, Fite, Giemsa, mucicarmine, periodic acid–Schiff, and fluorescence in situ hybridization stains. Only 2 of the color vision–deficient pathologists and cytotechnologists found digital slides more difficult than glass slides. Conclusions Color vision–deficient pathologists and cytotechnologists report that they have developed approaches to viewing slides that do not compromise their interpretations. Digital pathology may provide several approaches for aiding color vision–deficient pathologists with the interpretation of certain stains.
Performance measures for colonoscopy in inflammatory bowel disease patients: European Society of Gastrointestinal Endoscopy (ESGE) Quality Improvement Initiative
Dekker, Evelien , Nass, Karlijn J., Iacucci, Marietta , Murino, Alberto , Carretero, Cristina , Cortas, George, Despott, Edward J. , Keuchel, Martin , Monged, Ashraf , Neumann, Helmut , Omar, M. , Rutter, Matthew D. , Bisschops, Raf , Karstensen, John Gásdal , Neumann, Helmut , Pellisé, Maria , Rutter, Matthew D , Bisschops, Raf , Dekker, Evelien , Iacucci, Marietta , Sabino, João , Bugajski, Marek , East, James E. , Kaminski, Michal Filip , Löwenberg, Mark , Nardone, Olga Maria , Omar, Mahmoud M., Peyrin‐Biroulet, Laurent

Mayo Clinic

Endoscopy | August 1, 2022 | Volume: 54 | Issue: 09 | Pages: 904-915

10.1055/a-1874-0946 | PMID 35913069 Get It

AbstractThe European Society of Gastrointestinal Endoscopy (ESGE) presents a short list of performance measures for colonoscopy in inflammatory bowel disease (IBD) patients. Current performance measures for colonoscopy mainly focus on detecting (pre)malignant lesions. However, these performance measures are not relevant for all colonoscopy indications in IBD patients. Therefore, our aim was to provide endoscopy services across Europe and other interested countries with a tool for quality monitoring and improvement in IBD colonoscopy. Eight key performance measures and one minor performance measure were recommended for measurement and evaluation in daily endoscopy practice.
Lenalidomide therapy for primary myelodysplastic syndromes with isolated del(5q): Determinants of response and survival in a real‐world setting
Singh, Amritpal , Al‐Kali, Aref , Foran, James M. , Elliott, Michelle A. , Begna, Kebede H. , Badar, Talha , Khera, Nandita , Fleti, Farah, Abdelmagid, Maymona, Reichard, Kareen K., Pardanani, Animesh , Gangat, Naseema , Tefferi, Ayalew , Begna, Kebede , Pardanani, Animesh , Gangat, Naseema , Tefferi, Ayalew , Badar, Talha , Ketterling, Rhett P.

Mayo Clinic

American Journal of Hematology | August 1, 2022 | Volume: 97 | Issue: 10 | Pages: No page available

10.1002/ajh.26672 | PMID 35959963 Get It